We are live on ! Find out more
PHP

Parkman Healthcare Partners Portfolio holdings

AUM $970M
1-Year Est. Return 79.46%
This Fund
S&P 500
This Quarter Est. Return
+23.8%
1 Year Est. Return
+79.46%
3 Year Est. Return
+312.89%
5 Year Est. Return
+648.59%
10 Year Est. Return
–
AUM
$376M
AUM Growth
+$23.8M
Cap. Flow
-$13.2M
Cap. Flow %
-3.51%
Top 10 Hldgs %
36.6%
Holding
101
New
12
Increased
44
Reduced
25
Closed
20

Top Buys

Rank Stock Value
1
HUM icon
Humana
HUM
+$9.17M
2
PCVX icon
Vaxcyte
PCVX
+$6.2M
3
UTHR icon
United Therapeutics
UTHR
+$4.65M
4
SILK
Silk Road Medical, Inc. Common Stock
SILK
+$4.54M
5
BIIB icon
Biogen
BIIB
+$4.3M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$11.2M
2
WAT icon
Waters Corp
WAT
+$5.96M
3
RCM
R1 RCM Inc. Common Stock
RCM
+$5.16M
4
IONS icon
Ionis Pharmaceuticals
IONS
+$4.24M
5
IQV icon
IQVIA
IQV
+$4.02M

Sector Composition

Rank Sector Weight
1 Healthcare 98.13%
2 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANIP icon
26
ANI Pharmaceuticals
ANIP
$1.73B
$5.1M 1.36%
126,874
+8,933
+8% +$336K
SILK
27
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$4.93M 1.31%
+93,305
New +$4.54M
DAWN
28
DELISTED
Day One Biopharmaceuticals
DAWN
$4.83M 1.29%
224,483
+12,292
+6% +$252K
PHLT
29
DELISTED
Performant Healthcare Inc
PHLT
$4.76M 1.27%
1,319,675
+296,325
+29% +$694K
PRCT icon
30
Procept Biorobotics
PRCT
$1.22B
$4.67M 1.24%
112,318
+11,117
+11% +$477K
LNTH icon
31
Lantheus
LNTH
$6.57B
$4.63M 1.23%
90,923
+51,241
+129% +$3.16M
RYTM icon
32
Rhythm Pharmaceuticals
RYTM
$8.1B
$4.6M 1.22%
157,862
-30,127
-16% -$774K
LEGN icon
33
Legend Biotech
LEGN
$3.99B
$4.59M 1.22%
91,932
-29,295
-24% -$1.42M
SRPT icon
34
Sarepta Therapeutics
SRPT
$1.94B
$4.58M 1.22%
+35,314
New +$4.09M
SDGR icon
35
Schrodinger
SDGR
$1.39B
$4.26M 1.13%
227,951
+104,272
+84% +$2.16M
ETNB
36
DELISTED
89bio
ETNB
$4.24M 1.13%
332,880
+107,880
+48% +$971K
BIIB icon
37
Biogen
BIIB
$30.9B
$4.21M 1.12%
+15,217
New +$4.3M
EW icon
38
Edwards Lifesciences
EW
$53.6B
$4.07M 1.08%
54,579
-27,327
-33% -$2.11M
ACRS icon
39
Aclaris Therapeutics
ACRS
$860M
$3.89M 1.04%
247,159
+13,533
+6% +$218K
ACLX
40
DELISTED
Arcellx
ACLX
$3.75M 1%
121,093
-18,782
-13% -$431K
KRTX
41
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$3.71M 0.99%
18,900
+6,900
+58% +$1.48M
TMDX icon
42
Transmedics
TMDX
$3.02B
$3.42M 0.91%
55,351
+12,993
+31% +$691K
SUPN icon
43
Supernus Pharmaceuticals
SUPN
$2.78B
$3.39M 0.9%
94,906
+5,197
+6% +$181K
COO icon
44
Cooper Companies
COO
$15B
$3.31M 0.88%
40,000
-2,488
-6% -$184K
IQV icon
45
IQVIA
IQV
$39.8B
$3.15M 0.84%
15,374
-19,797
-56% -$4.02M
WAT icon
46
Waters Corp
WAT
$40.9B
$3.02M 0.8%
8,804
-18,826
-68% -$5.96M
KNSA icon
47
Kiniksa Pharmaceuticals
KNSA
$6.1B
$2.87M 0.76%
191,307
+65,115
+52% +$948K
IMVT icon
48
Immunovant
IMVT
$8.8B
$2.8M 0.75%
+158,006
New +$1.99M
ATEC icon
49
Alphatec Holdings
ATEC
$1.49B
$2.8M 0.75%
226,867
-318,266
-58% -$3.21M
VCYT icon
50
Veracyte
VCYT
$3.59B
$2.79M 0.74%
117,726
+56,843
+93% +$1.32M
1
2
3 4 5

Similar funds

LOIM
Liberty One Investment Management Libertyville, Illinois $970M AUM 12.15% 1-Year Est. Return
MGCM
Mane Global Capital Management New York $971M AUM 58.5% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
WAM
WNY Asset Management Williamsville, New York $967M AUM
GHC
Graham Holdings Company Arlington, Virginia $967M AUM 15.12% 1-Year Est. Return
SAM
Stansberry Asset Management Westlake, Texas $973M AUM 21.39% 1-Year Est. Return
TCCM
Two Creeks Capital Management New York $974M AUM 2.54% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Parkman Healthcare Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Parkman Healthcare Partners held 101 positions worth $376M, up 6.8% from $352M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Parkman Healthcare Partners withdrew a net $13.2M in Q4 2022, closing 20 positions and reducing 25 holdings. Its most notable exit was CVS Health, an estimated $11.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 96% a quarter earlier, followed by Industrials.

Against the trend, Parkman Healthcare Partners opened a new position in Humana worth $8.93M.

  • Parkman Healthcare Partners's largest Q4 2022 buy was Humana: 17,439 shares worth $8.93M.
  • Parkman Healthcare Partners added most to United Therapeutics in Q4 2022, an estimated $4.65M increase.
  • Parkman Healthcare Partners's biggest Q4 2022 reduction was Waters Corp, cutting an estimated $5.96M.
  • Parkman Healthcare Partners fully exited CVS Health in Q4 2022, selling an estimated $11.2M.
  • Parkman Healthcare Partners's ten largest holdings make up 37% of its $376M portfolio in Q4 2022.
  • Parkman Healthcare Partners opened 12 new positions and closed 20 in Q4 2022.
  • Parkman Healthcare Partners's portfolio value rose 6.8% quarter-over-quarter to $376M.

Based on Parkman Healthcare Partners's 13F filing for Q4 2022, filed 13 Feb 2023.